ClinVar Miner

Submissions for variant NM_001077365.2(POMT1):c.1503_1508dup (p.500_501RE[4])

dbSNP: rs727502853
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000150014 SCV000196874 uncertain significance Congenital muscular dystrophy 2014-04-24 criteria provided, single submitter clinical testing c.1569_1574dupGCGGGA: p.Arg526_Glu527dup in exon 16 in the POMT1 gene (NM_007171.3). The normal sequence with the base(s) that are inserted in braces is: GGGA{GCGGGA}ACGGGA. The c.1569_1574dupGCGGGA variant in the POMT1 gene has not been reported previously as a disease-causing mutation nor as a benign polymorphism, to our knowledge. The c.1569_1574dupGCGGGA variant causes an in-frame duplication that results in insertion of two amino acids, Arginine 526 and Glutamine 527, denoted p.Arg526_Glu527ins. The c.1569_1574dupGCGGGA variant was not observed in approximately 6,300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.1569_1574dupGCGGGA as a variant of unknown significance. The variant is found in POMT1 panel(s).
Eurofins Ntd Llc (ga) RCV000595188 SCV000706089 uncertain significance not provided 2017-02-02 criteria provided, single submitter clinical testing
Invitae RCV001301735 SCV001490913 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy 2022-10-24 criteria provided, single submitter clinical testing This variant, c.1569_1574dup, results in the insertion of 2 amino acid(s) of the POMT1 protein (p.Arg526_Glu527dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs727502853, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with POMT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 162593). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Revvity Omics, Revvity RCV000595188 SCV003809682 uncertain significance not provided 2020-11-03 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.